[
    [
        {
            "time": "2021-04-21",
            "original_text": "晚间重要公告2021年4月21日星期三",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "仿制药",
                    "一致性评价"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "晚间重要公告2021年4月21日星期三",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "国际基金巨头大幅增持恒瑞医药 孙飘扬个人斥3.16亿加码新药公司",
            "features": {
                "keywords": [
                    "国际基金",
                    "增持",
                    "孙飘扬",
                    "新药公司"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "国际基金巨头大幅增持恒瑞医药 孙飘扬个人斥3.16亿加码新药公司",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "股价暴跌 恒瑞医药董事长首次这样回应集采问题 连续下跌",
            "features": {
                "keywords": [
                    "股价暴跌",
                    "集采",
                    "董事长"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "股价暴跌 恒瑞医药董事长首次这样回应集采问题 连续下跌",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "首创证券---恒瑞医药：全年业绩符合预期，今年机遇与挑战并存【公司研究】",
            "features": {
                "keywords": [
                    "首创证券",
                    "恒瑞医药",
                    "业绩",
                    "预期"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "首创证券---恒瑞医药：全年业绩符合预期，今年机遇与挑战并存【公司研究】",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "A股资金流向（4月21日）：医美龙头获青睐，华为汽车概念遭抛售",
            "features": {
                "keywords": [
                    "A股",
                    "资金流向",
                    "医美",
                    "华为汽车"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "科技"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "A股资金流向（4月21日）：医美龙头获青睐，华为汽车概念遭抛售",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "渤海证券---医药行业周报：药品与耗材国采推进，结合估值与业绩探寻机会【行业研究】",
            "features": {
                "keywords": [
                    "渤海证券",
                    "医药行业",
                    "国采",
                    "估值",
                    "业绩"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "渤海证券---医药行业周报：药品与耗材国采推进，结合估值与业绩探寻机会【行业研究】",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-21",
            "original_text": "融券潮高峰已至，中芯国际、恒瑞医药、招商位列融券余额榜前三",
            "features": {
                "keywords": [
                    "融券",
                    "中芯国际",
                    "恒瑞医药",
                    "招商"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "科技",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "融券潮高峰已至，中芯国际、恒瑞医药、招商位列融券余额榜前三",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]